Kala制药(KALA)

1.96 -0.02 -1.0101%

今开:1.95昨收:1.98
最高:2.05 最低:1.94
涨停价:0.0跌停价:0.0
总市值:1.27343348E8

Kala制药的热门评论

Kala制药(KALA)2020-01-04 05:20

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-000161 Size: 5 KB 网页链接查看全文

Kala制药(KALA)2020-01-06 23:06

【异动】$Kala制药(KALA)$ 股价快速拉升,3分钟内涨幅达4.28%查看全文

Kala制药(KALA)2020-01-27 22:30

【异动】$Kala制药(KALA)$ 22:30跌幅达-4.41%,现价6.93美元查看全文

Kala制药(KALA)2020-01-27 22:30

【异动】$Kala制药(KALA)$ 22:30跌幅达-7.03%,现价6.74美元查看全文

Kala制药(KALA)2020-01-24 22:33

【异动】$Kala制药(KALA)$ 22:33股价创60日新高,现价7.49美元,涨幅3.60%查看全文

Kala制药(KALA)2020-01-13 20:40

$Kala制药(KALA)$ 8-K Current report, items 2.02, 7.01, and 9.01 Accession Number: 0001104659-20-003222 Act: 34 Size: 125 KB 网页链接查看全文

Kala制药(KALA)2020-01-04 05:20

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001179110-20-000156 Size: 5 KB 网页链接查看全文

Kala制药(KALA)2020-01-11 00:08

【异动】$Kala制药(KALA)$ 00:08盘中大涨12.08%,现价5.29美元查看全文

Kala制药(KALA)2020-01-22 23:01

【异动】$Kala制药(KALA)$ 23:01股价创60日新高,现价6.70美元,涨幅4.36%查看全文

Kala制药(KALA)2020-01-07 23:20

【异动】$Kala制药(KALA)$ 23:20涨幅达4.34%,现价5.05美元查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的最新评论

首次持股声明

Kala制药(KALA)10-20 04:12

$Kala制药(KALA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-21-004906 Size: 10 KB 网页链接查看全文

持股变动声明

Kala制药(KALA)10-20 04:12

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-004907 Size: 5 KB 网页链接查看全文

美股滚雪球10-19 15:48

$Esperion(ESPR)$ 裁员40%,$Kala制药(KALA)$ 药物获批后,快跌成毛票,biotech的商业化比研发还难。$百济神州(BGNE)$的商业化不一定会比其他biotech差,但一定不会比大药企好。查看全文

当期报告

Kala制药(KALA)10-18 20:12

$Kala制药(KALA)$ 8-K Current report, item 5.02 Accession Number: 0001558370-21-013248 Act: 34 Size: 159 KB 网页链接查看全文

超过5%股东持股披露「修订」

Kala制药(KALA)10-15 05:06

$Kala制药(KALA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000947871-21-001065 Act: 34 Size: 76 KB 网页链接查看全文

季度财报

Kala制药(KALA)08-06 04:06

$Kala制药(KALA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-21-010528 Act: 34 Size: 7 MB 网页链接查看全文

当期报告

Kala制药(KALA)08-05 19:06

$Kala制药(KALA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-010375 Act: 34 Size: 385 KB 网页链接查看全文

Takeabreak07-26 21:10

$Kala制药(KALA)$ Symphony Health sales and volume estimates are as follows: For the week ending July 16, 2021: INVELTYS: Approximately $828k (MBS Dollars) in sales and 2,985 pack units (both up +20.7% week-over-week) -About 74% were from new prescriptions and 26% from refill...查看全文

Takeabreak07-22 11:50

$Karyopharm(KPTI)$ $G1治疗(GTHX)$ $Kala制药(KALA)$ BTAI. Value destroyers?? Commercialization is more risky. Lesson learned??? Or patience is a virtue ??查看全文

Spica07-18 19:54

回复@Takeabreak: 我问了下一位做干眼症的朋友,他是这么回复的“”Eysuvis 应该还不错,但不会成为重磅。重要的原因:lotemax一直被off label用作治疗干眼,$Kala制药(KALA)$ 只是改了一个剂型,把off label变成approved。Lotemax医生可以随便开的,会一定程度限制了Eysuvis销售“//@Takeabreak:...查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Kala制药的公告

首次持股声明

$Kala制药(KALA)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001415889-21-004906 Size: 10 KB 网页链接

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-004907 Size: 5 KB 网页链接

当期报告

$Kala制药(KALA)$ 8-K Current report, item 5.02 Accession Number: 0001558370-21-013248 Act: 34 Size: 159 KB 网页链接

超过5%股东持股披露「修订」

$Kala制药(KALA)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000947871-21-001065 Act: 34 Size: 76 KB 网页链接

季度财报

$Kala制药(KALA)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-21-010528 Act: 34 Size: 7 MB 网页链接

当期报告

$Kala制药(KALA)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001558370-21-010375 Act: 34 Size: 385 KB 网页链接

$Kala制药(KALA)$ 内部交易: 2021-06-29,CHIEF SCIENTIFIC OFFICER,Chen Hongming ,卖出,5548普通股, $5.56

持股变动声明

$Kala制药(KALA)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001415889-21-003271 Size: 5 KB 网页链接

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF EXECUTIVE OFFICER,Iwicki Mark T ,卖出,7586普通股, $5.77

$Kala制药(KALA)$ 内部交易: 2021-06-28,CHIEF FINANCIAL OFFICER,Reumuth Mary ,卖出,2452普通股, $5.77

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24